Ceftazidime is a third-generation cephalosporin antibiotic primarily utilized to treat severe Gram-negative bacterial infections, including those caused by Pseudomonas aeruginosa. It functions by inhibiting… Read more
![Chemical structure of (1R,8S)-8-((E)-2-(2-Aminothiazol-4-yl)-2-(((1-(tert-butoxy)-2-methyl-1-oxopropan-2-yl)oxy)imino)acetamido)-7-oxo-4-(pyridin-1-ium-1-ylmethyl)-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R8S-8-E-2-2-Aminothiazol-4-yl-2-1-tert-butoxy-2-methyl-1-oxopropan-2-yloxyiminoacetamido-7-oxo-4-pyridin-1-ium-1-ylmethyl-2-thiabicyclo4.2.0oct-4-ene.png&w=3840&q=75)
![Chemical structure of (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 5-oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1301254-48-7-6R7R-7-Z-2-2-Aminothiazol-4-yl-2-2-carboxypropan-2-yloxyiminoacetamido-8-oxo-3-pyridin-1-ium-1-ylmethyl-5-thia-1-azabicyclo4.2.0oct-2-ene.png&w=3840&q=75)






![Chemical structure of (Z)-tert-Butyl 2-(((1-(2-aminothiazol-4-yl)-2-(benzo[d]thiazol-2-ylthio)-2-oxoethylidene)amino)oxy)-2-methylpropanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F89604-92-2-Z-tert-Butyl-2-1-2-aminothiazol-4-yl-2-benzodthiazol-2-ylthio-2-oxoethylideneaminooxy-2-methylpropanoate.png&w=3840&q=75)
















![Chemical structure of tert-Butyl (E)-2-(((1-(2-aminothiazol-4-yl)-2-(benzo[d]thiazol-2-ylthio)-2-oxoethylidene)amino)oxy)-2-methylpropanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-E-2-1-2-aminothiazol-4-yl-2-benzodthiazol-2-ylthio-2-oxoethylideneaminooxy-2-methylpropanoate.png&w=3840&q=75)


Ceftazidime is a third-generation cephalosporin antibiotic primarily utilized to treat severe Gram-negative bacterial infections, including those caused by Pseudomonas aeruginosa. It functions by inhibiting bacterial cell wall synthesis, specifically through binding to penicillin-binding proteins to disrupt peptidoglycan cross-linking. To ensure therapeutic efficacy and regulatory compliance, pharmaceutical laboratories utilize a specialized range of Ceftazidime reference standards. This category includes the parent drug, various pharmacopeial and non-pharmacopeial impurities, and degradation products formed through hydrolytic or oxidative pathways. These compounds are essential for rigorous impurity profiling, enabling accurate identification and quantification of related substances during drug development. Furthermore, stable isotope labelled versions serve as critical internal standards for quantitative analysis in complex matrices. These materials support comprehensive analytical method validation and quality control procedures, ensuring that the manufactured antibiotic meets established safety and purity specifications throughout its lifecycle.